Evoq Remedies IPO Details: Opening Date, Closing Date, Price

Evoq Remedies is a well-known trader of pharmaceutical raw materials, excipients, and bulk drugs at a reasonable price, serving consumers in Ahmedabad. Evoq Remedies is planning its IPO in mid of March 2022. Evoq Remedies’s IPO will be worth Rs. 9.72 crore, according to the DRHP filed with SEBI. Check below mentioned all details for Evoq Remedies IPO.

Evoq Remedies IPO
MobiKwik IPO Details

Achyut Healthcare IPO Details: Date, Price Band, Lot Size, Issue Size

Opening DateMar 17, 2022
Close DateMar 22, 2022
Price BandRs. 27 per equity share
Lot Size4000 Shares
Issue Size (Rs. Cr.)3,600,000 Eq Shares of Rs. 10 (aggregating up to Rs. 9.72 Cr)
Face ValueRs. 10 per equity share
Issue TypeFixed Price Issue IPO
Exchange BoardBSE, SME
Fresh Issue3,600,000 Eq Shares of Rs. 10 (aggregating up to Rs. 9.72 Cr)
Retail Shares Offered50%
NII (HNI) Shares Offered50%

About Evoq Remedies IPO

On February 24th, 2010, the company was incorporated as “Salus Life Science and Research Private Limited” in Ahmedabad, Gujarat. On July 15th, 2019, the name of the company was changed to “Evoq Remedies Private Limited.” Despite the fact that the company was founded in 2010, it did not begin operations until 2018.

The company is a well-known trader of pharmaceutical raw materials, excipients, and bulk drugs at a reasonable price, serving consumers in Ahmedabad. They obtain pharmaceutical Raw Materials, products, and chemicals from suppliers in India that have WHO-GMP accredited manufacturing facilities and emphasis on first-class distribution competence. EVOQ Remedies Limited is a Gujarat-based company that specialises in pharmaceutical raw materials, excipients, bulk drugs, and other related items.

EVOQ has a dedicated team of industry professionals with in-depth knowledge of the industry and skill in providing the finest solutions to meet their specific requirements. They source all of their items from reputable and certified manufacturers and importers who adhere to strict national and international quality and safety requirements.

Ahmedabad is home to EVOQ’s registered office, corporate headquarters, and storage facilities. In the healthcare sector, EVOQ is a trading company that sells a diverse range of products.

Excipients, Nutraceuticals, Pellets, Solvents, Sweetners, Vitamins, Amino Acids, Bulk Drugs, Dairy Products, and Active Pharmaceuticals Ingredients are the main segments of pharmaceutical raw materials that EVOQ trades in.

Promoters of Evoq Remedies IPO

Promoters of Evoq Remedies IPO are Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel. Mr. Bhumishth Narendrabhai Patel, the Company’s founder, is 38 years old. He has been named Chairman and Managing Director of the company.


Evoq Remedies IPO FAQs

What is Evoq Remedies IPO?

The Evoq Remedies IPO is a small business IPO with 3,600,000 equity shares with a face value of ten rupees, for a total of Rs. 9.72 crores. The issue’s price per equity share is set at Rs. 27. A minimum order quantity of 4000 shares is required.

When Evoq Remedies IPO will open?

The Evoq Remedies IPO opens on Mar 17, 2022 and closes on Mar 22, 2022.

What is the lot size of Evoq Remedies IPO?

Evoq Remedies IPO lot size is 4000 Shares and the minimum order quantity is 4000 Shares.

How to apply for Evoq Remedies IPO?

You can apply in Evoq Remedies IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services.

When Evoq Remedies IPO allotment?

The basis of allotment for the Evoq Remedies IPO will be finalised on (to be announced), and the assigned shares will be credited to your demat account by that date (to be announced).

When is Evoq Remedies IPO listing date?

The Evoq Remedies IPO listing date is not yet announced. The tentative date of Evoq Remedies IPO listing is (to be announced).

Who is the registrar of Evoq Remedies IPO?

Bigshare Services Pvt Ltd is the registrar for the IPO.